It would give immediate immunity against the disease and could be given as emergency treatment to hospitalized patients and nursing home residents to help contain the outbreak. According to the Guardian, this would be the drug under study in Great Britain for Covid 19.
The drug was developed from University College London Hospital (Uclh) and AstraZeneca. The team hopes the study will show that the antibody cocktail protects against the coronavirus for between six and 12 months.
If approved, it will be administered to those who have been exposed to Covid-19 in the previous eight days.
According to the newspaper, the drug could be administered to family members, still negative, of people who tested positive to the test to avoid contagion or be used for people who frequent areas particularly at risk, such as university students, among whom the virus has sparked several epidemic outbreaks in Great Britain.
It may be available from March-April and be decisive above all in the phase in which the vaccine has not yet arrived to give herd immunity.
The drug would also give immediate immunity, unlike current vaccines which need a few days before guaranteeing it.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
